{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:24:44Z","timestamp":1794695084532,"version":"4.9.1"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,11,15]]},"DOI":"10.2169\/internalmedicine.6888-25","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:08:49Z","timestamp":1773698929000},"page":"3024-3031","source":"Crossref","is-referenced-by-count":0,"title":["Relapse of Membranous Nephropathy Following Adrenalectomy for Cushing Syndrome"],"prefix":"10.2169","volume":"65","author":[{"given":"Haruki","family":"Mae","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Kanzaki","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanae","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ueda","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Tsuboi","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yokoo","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ronco P, Beck L, Debiec H, et al. Membranous nephropathy. Nat Rev Dis Primers 30;7: 69, 2021.","DOI":"10.1038\/s41572-021-00303-z"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Alsharhan L, Beck LH. Membranous nephropathy: core curriculum 2021. Am J Kidney Dis 77: 440-453, 2021.","DOI":"10.1053\/j.ajkd.2020.10.009"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Wada T, Ishimoto T, Nakaya I, et al. A digest of the Evidence-Based Clinical Practice Guideline for Nephrotic Syndrome 2020. Clin Exp Nephrol 25: 1277-1285, 2021.","DOI":"10.1007\/s10157-021-02098-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BMK, Colao A. Complications of Cushing's syndrome: state of the art. Lancet Diabetes Endocrinol 4: 611-629, 2016.","DOI":"10.1016\/S2213-8587(16)00086-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Petramala L, Olmati F, Conforti MG, et al. Autoimmune diseases in patients with Cushing's syndrome after resolution of hypercortisolism: case reports and literature review. Int J Endocrinol 2018: 1-7, 2018.","DOI":"10.1155\/2018\/1464967"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nyanyo DD, Mikamoto M, Galbiati F, et al. Autoimmune disorders associated with surgical remission of Cushing's disease: a cohort study. Ann Intern Med 177: 315-323, 2024.","DOI":"10.7326\/M23-2024"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Da Mota F, Murray C, Ezzat S. Overt immune dysfunction after Cushing's syndrome remission: a consecutive case series and review of the literature. J Clin Endocrinol Metab 96: E1670-E1674, 2011.","DOI":"10.1210\/jc.2011-1317"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tatsi C, Keil M, Lyssikatos C, Belyavskaya E, Stratakis C, Lodish M. Incidence of autoimmune and related disorders after resolution of endogenous Cushing syndrome in children. Horm Metab Res 50: 290-295, 2018.","DOI":"10.1055\/s-0044-101144"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nieman LK, Biller BMK, Findling JW, et al. Treatment of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 100: 2807-2831, 2015.","DOI":"10.1210\/jc.2015-1818"},{"key":"10","unstructured":"10. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62: 2569-2581, 2010."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Humphrey MB, Russell L, Danila MI, et al. 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Rheumatol 75: 2088-2102, 2023.","DOI":"10.1002\/art.42646"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hasenmajer V, Sbardella E, Sciarra F, Minnetti M, Isidori AM, Venneri MA. The immune system in Cushing's syndrome. Trends Endocrinol Metab 31: 655-669, 2020.","DOI":"10.1016\/j.tem.2020.04.004"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Di Matteo A, Bathon JM, Emery P. Rheumatoid arthritis. Lancet 402: 2019-2033, 2023.","DOI":"10.1016\/S0140-6736(23)01525-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Miyazaki R, Ueda H, Hayashi A, et al. Neural epidermal growth factor-like 1-positive membranous nephropathy with rheumatoid arthritis. Kidney Int Rep 8: 921-924, 2023.","DOI":"10.1016\/j.ekir.2022.12.026"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Iida A, Wada Y, Hayashi J, et al. Membranous nephropathy caused by rheumatoid arthritis. CEN Case Rep 8: 233-238, 2019.","DOI":"10.1007\/s13730-019-00399-z"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Liu W, Gao C, Dai H, et al. Immunological pathogenesis of membranous nephropathy: focus on PLA2R1 and its role. Front Immunol 10: 1809, 2019.","DOI":"10.3389\/fimmu.2019.01809"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rovin BH, Adler SG, Barratt J, et al. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int 100: S1-S276, 2021.","DOI":"10.1016\/j.kint.2021.05.021"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hofstra JM, Wetzels JFM. Management of patients with membranous nephropathy. Nephrology Dialysis Transplantation 27: 6-9, 2012.","DOI":"10.1093\/ndt\/gfr371"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Fuiano G, Stanziale P, Balletta M, et al. Effectiveness of steroid therapy in different stages of membranous nephropathy. Nephrol Dial Transplant 4: 1022-1029, 1989.","DOI":"10.1093\/ndt\/4.12.1022"},{"key":"20","unstructured":"20. Ericson-Neilsen W, Kaye AD. Steroids: pharmacology, complications, and practice delivery issues. Ochsner J 14: 2014."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Peleg Y, Bomback AS, Canetta PA, Radhakrishnan J, Appel GB, Ahn W. Late relapses of membranous nephropathy: a case series. Kidney360 2: 974-982, 2021.","DOI":"10.34067\/KID.0007712020"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kanigicherla DAK, Short CD, Roberts SA, et al. Long-term outcomes of persistent disease and relapse in primary membranous nephropathy. Nephrol Dial Transplant 31: 2108-2114, 2016.","DOI":"10.1093\/ndt\/gfv435"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/22\/65_6888-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:11:13Z","timestamp":1794694273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/22\/65_6888-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,15]]},"references-count":22,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6888-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,11,15]]},"article-number":"6888-25"}}